Debt-to-equity of Foghorn Therapeutics Inc. from 30 Jun 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Foghorn Therapeutics Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2021 to 31 Dec 2025.
  • Foghorn Therapeutics Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was -364%, a 50% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Foghorn Therapeutics Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 -364% +370% +50% 31 Dec 2025
Q3 2025 -456% +186% +29% 30 Sep 2025
Q2 2025 -608% -28% -4.8% 30 Jun 2025
Q1 2025 -888% -363% -69% 31 Mar 2025
Q4 2024 -734% -4.4% -0.6% 31 Dec 2024
Q3 2024 -642% +548% +46% 30 Sep 2024
Q2 2024 -580% +2654% +82% 30 Jun 2024
Q1 2024 -524% -3938% -115% 31 Mar 2024
Q4 2023 -729% -1864% -164% 31 Dec 2023
Q3 2023 -1190% -1878% -273% 30 Sep 2023
Q2 2023 -3234% -3688% -812% 30 Jun 2023
Q1 2023 3414% +3118% +1054% 31 Mar 2023
Q4 2022 1135% +954% +527% 31 Dec 2022
Q3 2022 687% +594% +641% 30 Sep 2022
Q2 2022 454% +282% +163% 30 Jun 2022
Q1 2022 296% 31 Mar 2022
Q4 2021 181% 31 Dec 2021
Q3 2021 93% 30 Sep 2021
Q2 2021 172% 30 Jun 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.